Pakarinen, Emmi
Lindholm, Päivi http://orcid.org/0000-0003-3022-5035
Saarma, Mart http://orcid.org/0000-0001-5543-7160
Lindahl, Maria http://orcid.org/0000-0002-5674-8830
Funding for this research was provided by:
Academy of Finland (1310891, 117044)
Jane ja Aatos Erkon Säätiö
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 10 June 2021
Revised: 11 January 2022
Accepted: 19 January 2022
First Online: 7 February 2022
Declarations
:
: Authors declare that they do not have any conflicts of interest with the content of this manuscript. ML, PL, and MS are inventors of a patent Neurotrophic factor MANF and uses thereof (9,592,270) and MS and PL are inventors of the CDNF-related patent (7,452,969). Both patents are owned by Herantis Pharma Plc.
: All experiments were carried out according to regulations set by the Finnish Animal Experiment Board (licenses ESAVI/11865/04.10.07/2017 and ESAVI/37304/2020).